ABH Healthcare (NSE:ABH) Cash Conversion Cycle: 118.36 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ABH ABH Healthcare Ltd NSE:ABH
15 GF Score
Price ₹39.80
! 2 Warning Signs
View Full Analysis

What is ABH Healthcare Cash Conversion Cycle?

ABH Healthcare NSE:ABH -16.56% 15 Cash Conversion Cycle is 118.36 as of Mar. 2025. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

ABH Healthcare's Days Sales Outstanding for the three months ended in Mar. 2025 was 139.785.
ABH Healthcare's Days Inventory for the three months ended in Mar. 2025 was 56.205.
ABH Healthcare's Days Payable for the three months ended in Mar. 2025 was 77.627.
Therefore, ABH Healthcare's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 118.36.


ABH Healthcare  (NSE:ABH) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


ABH Healthcare Cash Conversion Cycle Related Terms


ABH Healthcare Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for ABH Healthcare's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABH Healthcare Cash Conversion Cycle Chart

ABH Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Cash Conversion Cycle
-182.16 6.11 52.09 95.60

ABH Healthcare Quarterly Data
Mar25
Cash Conversion Cycle 118.36

NSE:ABH vs : Cash Conversion Cycle Comparison

For the Medical Care Facilities subindustry, ABH Healthcare's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABH Healthcare Cash Conversion Cycle vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where ABH Healthcare's Cash Conversion Cycle falls into.


NSE:ABH
15GF Score
ABH Healthcare Ltd NSE:ABH
Cash Conversion Cycle is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABH Healthcare Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

ABH Healthcare's Cash Conversion Cycle for the fiscal year that ended in Mar. 2025 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=117.481+43.177-65.062
=95.60

ABH Healthcare's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=139.785+56.205-77.627
=118.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 118.36 mean?
ABH Healthcare (NSE:ABH) has a Cash Conversion Cycle of 118.36 as of Mar. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on ABH Healthcare and its competitors.
Is ABH Healthcare's Cash Conversion Cycle too high?
ABH Healthcare's current Cash Conversion Cycle is 118.36. The Healthcare Providers & Services industry median Cash Conversion Cycle is 17.69. ABH Healthcare's value of 118.36 is 569.1% above this industry median. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's Cash Conversion Cycle compare to ?
ABH Healthcare's Cash Conversion Cycle of 118.36 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 17.69. ABH Healthcare's value of 118.36 is 569.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 17.69, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current Cash Conversion Cycle of 118.36 is 569.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 17.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current Cash Conversion Cycle is 118.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current Cash Conversion Cycle of 118.36. The current Cash Conversion Cycle is 118.36 and 569.1% above the Healthcare Providers & Services industry median of 17.69. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current Cash Conversion Cycle is 118.36 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ABH Healthcare Business Description

Comparable Companies
Address Martyr Anil Baghi Road, Anil Baghi Hospital, Ferozepur, PB, IND, 152002
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score

Get the complete analysis for NSE:ABH

Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.80
Price